Regulation of p53 in response to DNA damage
The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.
Abstract
Activation of p53 can occur in response to a number of cellular stresses, including DNA damage, hypoxia and nucleotide deprivation. Several forms of DNA damage have been shown to activate p53, including those generated by ionising radiation (IR), radio-mimetic drugs, ultraviolet light (UV) and chemicals such as methyl methane sulfonate (MMS). Under normal conditions, p53 levels are maintained at a low state by virtue of the extremely short-half life of the polypeptide. In addition to this, p53 normally exists in an largely inactive state that is relatively inefficient at binding to DNA and activating transcription. Activation of p53 in response to DNA damage is associated with a rapid increase in its levels and with an increased ability of p53 to bind DNA and mediate transcriptional activation. This then leads to the activation of a number of genes whose products trigger cell-cycle arrest, apoptosis, or DNA repair. Recent work has suggested that this regulation is brought about largely through DNA damage triggering a series of phosphorylation, de-phosphorylation and acetylation events on the p53 polypeptide. Here, we discuss the nature of these modifications, the enzymes that bring them about, and how changes in p53 modification lead to p53 activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UV-induced phosphorylation at Serine 15 increased p53 stability and protein level that associated with DNA damage [61].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [61]
In the citing paper
“Under normal conditions, cellular p53 protein levels are very low owing to strict control by its negative regulators MDM2 and MDMX, which promote p53 degradation through ubiquitination.27,28”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [28]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 4,252
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 2×
“Interaction of Mdm2 with this N-terminal region of p53 has been demonstrated to inhibit the ability of p53 to activate transcription (Momand et al., 1992; Oliner et al., 1993).”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“Initial clues suggesting that ATM may be involved in regulation of p53 in response to DNA damage came from observations that cell cycle checkpoint controls and up-regulation of p53 in response to IR are defective in A-T cells (Kastan et al., 1992; Khanna and Lavin, 1993; Canman et al., 1994).”
BackgroundHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“Further support for this idea has been provided by the demonstration that certain histone acetyl-transferase (HAT) enzymes correspond to key transcriptional coactivators, such as CBP/p300 and PCAF (for reviews see Grunstein, 1997; Kouzarides, 1999).”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785 · cited 1×
“The gene mutated in ataxia-telangiectasia patients was mapped to human chromosome 11q2223, and the gene, termed ATM, has been cloned (Gatti et al., 1988; Savitsky et al., 1995).”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 2×
“Thus, in addition to potentially playing a role in acetylating histones at p53-dependent promoters, CBP/p300 has been shown to be able to acetylate p53 at lysine-373 and lysine-382, whilst PCAF can acetylate p53 at lysine-320 (Gu and Roeder, 1997; Sakaguchi, 1998; Liu et al., 1999).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344 · cited 4×
“Elevated levels of p21 then inhibit the cyclin E/cdk2 and cyclin A/cdk2 kinases, thus preventing these kinases from promoting cell cycle progression (for review, see Ko and Prives, 1996; Levine, 1997).”
BackgroundInfluentialStructure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206 · cited 1×
“These observations are particularly interesting given that serine-20 resides in the region of p53 that binds to Mdm2 (Picksley et al., 1994; Kussie et al., 1996).”
BackgroundDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · cited 6×
“Furthermore, phosphorylation of p53 by DNA-PK in vitro has been reported to disrupt the interaction of p53 with Mdm2 and alleviate Mdm2-mediated inhibition of p53 dependent transcription (Shieh et al., 1997).”
BackgroundMethodInfluentialActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042 · cited 4×
“This idea has recently received strong support by the observations that ATM mediates phosphorylation of serine-15 of p53 in vitro, and that this kinase activity is activated in response to IR, but not UV (Banin et al., 1998; Canman et al., 1998; Khanna et al., 1998).”
BackgroundInfluentialOncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949 · cited 1×
“Similarly, HDM2 is ampli®ed in a large proportion of human sarcomas (Oliner et al., 1992).”
BackgroundThe p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801 · cited 1×
“Interestingly, the promoter of the Mdm2 gene contains a p53 binding site and is transcribed in a p53dependent manner (Barak et al., 1993; Perry et al., 1993; Wu et al., 1993).”
BackgroundEnhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,451 · cited 1×
“Interaction of Mdm2 with this N-terminal region of p53 has been demonstrated to inhibit the ability of p53 to activate transcription (Momand et al., 1992; Oliner et al., 1993).”
BackgroundLinkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322
The complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
Signalling through the lipid products of phosphoinositide-3-OH kinase
Toker, A., & Cantley, L. C. (1997) · Nature · doi:10.1038/42648 · Cited by 1,304 · cited 1×
“Members of the PI 3-kinase family were originally identi®ed by their ability to mediate intra-cellular signalling events by way of phosphorylating inositol lipids (for review see Toker and Cantley, 1997).”
Backgroundmdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290 · cited 1×
“Interestingly, the promoter of the Mdm2 gene contains a p53 binding site and is transcribed in a p53dependent manner (Barak et al., 1993; Perry et al., 1993; Wu et al., 1993).”
BackgroundIs a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251 · cited 1×
“In addition, p53 has been implicated in triggering cellcycle arrest within the G2 phase of the cell cycle, and the available evidence suggests that this is achieved, at least in part, by p53 inducing the expression of the protein 14-3-3 sigma (Hermeking et al., 1997).”
BackgroundThe DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen
Gottlieb, T. M., & Jackson, S. P. (1993) · Cell · doi:10.1016/0092-8674(93)90057-w · Cited by 1,243 · cited 1×
“Puri®cation and subsequent analysis of DNA-PK by a number of laboratories revealed that DNA-PK consists of a large catalytic subunit (DNAPKcs) that is targeted to DNA ends by the Ku heterodimer, which consists of the polypeptides Ku70 and Ku80 (Dvir et al., 1993; Gottlieb and Jackson, 1993).”
BackgroundSelf-citationCarney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le Beau, M., Yates, J. R., Hays, L., Morgan, W. F., & Petrini, J. H. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81175-7 · Cited by 1,226 · cited 1×
“Recently the NBS1 gene was cloned by conventional gene mapping techniques (Matsuura et al., 1998a; Varon et al., 1998), and through a biochemical puri®cation that yielded the NBS1 gene product (Carney et al., 1998).”
MethodDi Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215 · cited 1×
“In addition, the fact that p53 induction can initiate prolonged cell-cycle arrest suggests that it also provides a mechanism for permanently removing damaged, and potentially mutated cells from the dividing cell population (Di Leonardo et al., 1994).”
BackgroundDNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204 · cited 3×
“Recently, by the use of acetylation-speci®c antibodies raised against these acetylation sites, Sakaguchi et al. (1998) have demonstrated that lysine-382 is acetylated in response to IR or UV-induced DNA damage.”
BackgroundInfluentialNibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome
Varon, R., Vissinga, C., Platzer, M., Cerosaletti, K. M., Chrzanowska, K. H., Saar, K., Beckmann, G., Seemanová, E., Cooper, P. R., Nowak, N. J., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81174-5 · Cited by 1,079 · cited 1×
“Recently the NBS1 gene was cloned by conventional gene mapping techniques (Matsuura et al., 1998a; Varon et al., 1998), and through a biochemical puri®cation that yielded the NBS1 gene product (Carney et al., 1998).”
MethodA role for ATR in the DNA damage-induced phosphorylation of p53
Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S.-Y., Taya, Y., Prives, C., & Abraham, R. T. (1999) · Genes & Development · doi:10.1101/gad.13.2.152 · Cited by 1,046 · cited 4×
“Over-expression of kinase-dead ATR has also been shown to completely abrogate serine-15 phosphorylation and up-regulation of p53 levels in response to UV, implicating ATR in the detection and signalling of DNA damage induced by this agent (Tibbetts et al., 1999).”
BackgroundInfluentialEckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., & Livingston, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.8.869 · Cited by 1,045 · cited 5×
“Thus, in addition to potentially playing a role in acetylating histones at p53-dependent promoters, CBP/p300 has been shown to be able to acetylate p53 at lysine-373 and lysine-382, whilst PCAF can acetylate p53 at lysine-320 (Gu and Roeder, 1997; Sakaguchi, 1998; Liu et al., 1999).”
BackgroundInfluentialRegulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909 · cited 4×
“One of the ®rst indications that DNA binding by p53 might be subject to control was provided by the observation that bacterially-expressed recombinant p53 exists in a latent form that is relatively ine cient at binding to p53 responsive DNA elements (Hupp et al., 1992).”
BackgroundInfluentialUV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
Maltzman, W., & Czyzyk, L. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.9.1689 · Cited by 893 · cited 2×
“A variety of studies have revealed that p53 has an extremely short half-life in an unstressed cell, but becomes markedly more stable following DNA damage (Maltzman and Czyzyk, 1984; Price and Calderwood, 1993; Maki and Howley, 1997).”
BackgroundThe DNA-dependent protein kinase
Smith, G. C. M., & Jackson, S. P. (1999) · Genes & Development · doi:10.1101/gad.13.8.916 · Cited by 887 · cited 2×
“DNA-PK was identi®ed originally as a protein serine/ threonine kinase capable of being activated in vitro in a DNA end-dependent manner (for review see Smith and Jackson, 1999).”
BackgroundSelf-citationDNA damage induces phosphorylation of the amino terminus of p53
Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., & Kastan, M. B. (1997) · Genes & Development · doi:10.1101/gad.11.24.3471 · Cited by 818 · cited 5×
“…for e ective phosphorylation of p53 at serine-15 in response to IR, A-T cells appear to be fully pro®cient in stabilizing p53 and phosphorylating p53 on serine-15 in response to UV and various other forms of DNA damaging agents (Khanna and Lavin, 1993; Canman et al., 1994; Siliciano et al., 1997).”
BackgroundMethodInfluentialLu, X. (1993) · Cell · doi:10.1016/0092-8674(93)90496-d · Cited by 778 · cited 1×
“In addition, although the p53 response is severely defective in A-T cells exposed to IR, in some instances the response is not completely absent, but severely delayed (Lu and Lane, 1993; Canman et al., 1994).”
Backgroundp53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage
Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776 · cited 3×
“Thus, in addition to potentially playing a role in acetylating histones at p53-dependent promoters, CBP/p300 has been shown to be able to acetylate p53 at lysine-373 and lysine-382, whilst PCAF can acetylate p53 at lysine-320 (Gu and Roeder, 1997; Sakaguchi, 1998; Liu et al., 1999).”
BackgroundFakharzadeh, S. S., Trusko, S. P., & George, D. L. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07676.x · Cited by 704 · cited 1×
“Mdm2 was initially identi®ed by virtue of the fact that it is ampli®ed in the mouse tumorigenic cell line 3T3DM (Fakharzadeh et al., 1991).”
BackgroundBinding and modulation of p53 by p300/CBP coactivators
Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., & Livingston, D. M. (1997) · Nature · doi:10.1038/42981 · Cited by 693 · cited 2×
“More recently, these claims have been substantiated by reports that CBP/ p300 can bind to the N-terminus of p53 and a ect its transcriptional activity and cell cycle regulatory functions (Avantaggiati et al., 1997; Gu et al., 1997a; Lill et al., 1997; Scolnick et al., 1997).”
BackgroundThe novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins
McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D., & Cole, M. D. (1998) · Cell · doi:10.1016/s0092-8674(00)81479-8 · Cited by 693 · cited 1×
“However, unlike DNA-PK, ATM and ATR, TRRAP appears to contain no intrinsic kinase activity, but instead copuri®es both in yeast and mammals with protein complexes that contain HAT activity (Grant et al., 1998; McMahon et al., 1998; Saleh et al., 1998; Vassilev et al., 1998).”
BackgroundLocalization of an ataxia-telangiectasia gene to chromosome 11q22–23
Gatti, R. A., Berkel, I., Boder, E., Braedt, G., Charmley, P., Concannon, P., Ersoy, F., Foroud, T., Jaspers, N. G. J., Lange, K., et al. (1988) · Nature · doi:10.1038/336577a0 · Cited by 686 · cited 1×
“The gene mutated in ataxia-telangiectasia patients was mapped to human chromosome 11q2223, and the gene, termed ATM, has been cloned (Gatti et al., 1988; Savitsky et al., 1995).”
BackgroundRecruitment of p300/CBP in p53-Dependent Signal Pathways
Avantaggiati, M. L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A. S., & Kelly, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80304-9 · Cited by 669 · cited 1×
“More recently, these claims have been substantiated by reports that CBP/ p300 can bind to the N-terminus of p53 and a ect its transcriptional activity and cell cycle regulatory functions (Avantaggiati et al., 1997; Gu et al., 1997a; Lill et al., 1997; Scolnick et al., 1997).”
BackgroundRequirement for Ku80 in growth and immunoglobulin V(D)J recombination
Nussenzweig, A., Chen, C., da Costa Soares, V., Sanchez, M., Sokol, K., Nussenzweig, M. C., & Li, G. C. (1996) · Nature · doi:10.1038/382551a0 · Cited by 663 · cited 1×
“…a targeted disruption in the genes for Ku80 or Ku70 (Bogue et al., 1996; Fried et al., 1996; Guidos et al., 1996; Huang et al., 1996b; Jongmans et al., 1996; Nacht et al., 1996; Candeias et al., 1997; Gu et al., 1997b; Nussenzweig et al., 1996; Rathmell et al., 1997; Abraham et al., 1999).”
BackgroundLin, J., Chen, J., Elenbaas, B., & Levine, A. J. (1994) · Genes & Development · doi:10.1101/gad.8.10.1235 · Cited by 653 · cited 2×
“Furthermore, mutational analysis of the p53 N-terminus has revealed that the amino acid residues required for p53mediated transcriptional-activation overlap significantly with those required for interaction with Mdm2 (Lin et al., 1994).”
BackgroundIn vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki, C. G., Huibregtse, J. M., & Howley, P. M. (1996) · PubMed · Cited by 645
Prives, C. (1998) · Cell · doi:10.1016/s0092-8674(00)81774-2 · Cited by 623 · cited 1×
“Speci®cally, work on ARF demonstrated that it can bind to Mdm2 and thus prevent Mdm2-mediated proteolytic destruction of p53 (for review, see Prives, 1998).”
Histone acetylases and deacetylases in cell proliferation
Kouzarides, T. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80006-9 · Cited by 601 · cited 1×
“Further support for this idea has been provided by the demonstration that certain histone acetyl-transferase (HAT) enzymes correspond to key transcriptional coactivators, such as CBP/p300 and PCAF (for reviews see Grunstein, 1997; Kouzarides, 1999).”
BackgroundSynergistic activation of transcription by CBP and p53
Gu, W., Shi, X.-L., & Roeder, R. G. (1997) · Nature · doi:10.1038/42972 · Cited by 596 · cited 2×
“…a targeted disruption in the genes for Ku80 or Ku70 (Bogue et al., 1996; Fried et al., 1996; Guidos et al., 1996; Huang et al., 1996b; Jongmans et al., 1996; Nacht et al., 1996; Candeias et al., 1997; Gu et al., 1997b; Nussenzweig et al., 1996; Rathmell et al., 1997; Abraham et al., 1999).”
BackgroundCliby, W. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.159 · Cited by 536 · cited 1×
“…that overexpression of a kinase-inactive (kinase-dead) dominant negative form of ATR renders cells hypersensitive to a variety of DNA damaging agents, illustrating that ATR is indeed involved in the detection and signalling of DNA damage in mammalian cells (Cliby et al., 1998; Wright et al., 1998).”
BackgroundNuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6
Freedman, D. A., & Levine, A. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7288 · Cited by 518 · cited 1×
“More speci®cally, Mdm2 is believed to translocate p53 from the nucleus of the cell into the cytoplasm, where it then undergoes degradation (Dobbelstein et al., 1998; Freedman and Levine, 1998; Tao and Levine, 1999).”
BackgroundLees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E., & Anderson, C. W. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5041 · Cited by 487 · cited 1×
“Consistent with the above signalling model, DNAPK has been shown to be capable of phosphorylating p53 on serine-15 and serine-37 in vitro in a DNAdependent manner (Lees-Miller et al., 1990; 1992).”
BackgroundATM associates with and phosphorylates p53: mapping the region of interaction
Khanna., K. K., Keating, K. E., Kozlov, S., Scott, S., Gatei, M., Hobson, K., Taya, Y., Gabrielli, B., Chan, D., Lees-Miller, S. P., et al. (1998) · Nature Genetics · doi:10.1038/3882 · Cited by 486 · cited 1×
“This idea has recently received strong support by the observations that ATM mediates phosphorylation of serine-15 of p53 in vitro, and that this kinase activity is activated in response to IR, but not UV (Banin et al., 1998; Canman et al., 1998; Khanna et al., 1998).”
BackgroundATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins
Waterman, M. J. F., Stavridi, E. S., Waterman, J. L. F., & Halazonetis, T. D. (1998) · Nature Genetics · doi:10.1038/542 · Cited by 460 · cited 3×
“In addition to phosphorylation of p53 occurring in response to DNA damage, Waterman et al. (1998) have provided persuasive evidence that de-phosphorylation of p53 in response to DNA damage may also regulate p53 activity.”
BackgroundInfluentialRegulation of p53 function and stability by phosphorylation.
Ashcroft, M., Kubbutat, M. H. G., & Vousden, K. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1751 · Cited by 452 · cited 2×
“…one recent report revealed that mutation of all known phosphorylation sites in the N-terminus and C-terminus of p53 has no dramatic e ect on the ability of mutant p53 to activate transcription of receptor genes nor on its ability to be stabilized in response to DNA damage (Ashcroft et al., 1999).”
BackgroundGrowth Retardation and Leaky SCID Phenotype of Ku70-Deficient Mice
Gu, Y., Seidl, K. J., Rathbun, G. A., Zhu, C., Manis, J. P., van der Stoep, N., Davidson, L., Cheng, H.-L., Sekiguchi, J. M., Frank, K., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80386-6 · Cited by 451 · cited 2×
“…a targeted disruption in the genes for Ku80 or Ku70 (Bogue et al., 1996; Fried et al., 1996; Guidos et al., 1996; Huang et al., 1996b; Jongmans et al., 1996; Nacht et al., 1996; Candeias et al., 1997; Gu et al., 1997b; Nussenzweig et al., 1996; Rathmell et al., 1997; Abraham et al., 1999).”
BackgroundSmall peptides activate the latent sequence-specific DNA binding function of p53
Hupp, T. R., Sparks, A., & Lane, D. P. (1995) · Cell · doi:10.1016/0092-8674(95)90165-5 · Cited by 434 · cited 3×
“…the observation that low doses of UV irradiation can induce p53-dependent transcription in the absence of a signi®cant increase in p53 protein levels, suggests that the cell has developed ways to directly regulate the ability of p53 to mediate transcriptional activation (Hupp et al., 1995).”
BackgroundPhosphorylation of p53 Serine 15 Increases Interaction with CBP
Lambert, P. F., Kashanchi, F., Radonovich, M. F., Shiekhattar, R., & Brady, J. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33048 · Cited by 423 · cited 1×
“Notably, phosphorylation events at serine33 and/or serine-37 (Sakaguchi, 1998), in addition to serine-15 (Lambert et al., 1998), have been implicated in recruiting CBP/p300 to p53 and controlling p53 acetylation status in vitro.”
BackgroundLees-Miller, S. P., Chen, Y. R., & Anderson, C. W. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.12.6472 · Cited by 417 · cited 2×
“…within the N-terminal 27 amino acid residues of p53 (Jamal and Zi , 1995), the DNAdependent protein kinase (DNA-PK) at serine-15 and serine-37 (Lees-Miller et al., 1990; Shieh et al., 1997) in addition to the DNA-PK related kinases, ATM at serine-15, and ATR at serine-15 and serine-37 (Banin…”
BackgroundLee, S., Elenbaas, B., Levine, A., & Griffith, J. (1995) · Cell · doi:10.1016/s0092-8674(05)80006-6 · Cited by 405 · cited 1×
“Furthermore, synthetic peptides derived from the p53 C-terminus can interact with the C-terminal regulatory domain and activate p53 sequence-speci®c DNA binding (Hupp et al., 1995; Jayaraman and Prives, 1995; Lee et al., 1995; Selivanova et al., 1997; Muller-Tiemman et al., 1998).”
BackgroundHuang, L. C., Clarkin, K. C., & Wahl, G. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4827 · Cited by 384 · cited 2×
“…in DNA-PKcs, or in mice containing a targeted disruption in the genes for Ku80 or Ku70 (Bogue et al., 1996; Fried et al., 1996; Guidos et al., 1996; Huang et al., 1996b; Jongmans et al., 1996; Nacht et al., 1996; Candeias et al., 1997; Gu et al., 1997b; Nussenzweig et al., 1996; Rathmell et al.,…”
BackgroundThe Schizosaccharomyces pombe rad3 checkpoint gene.
Bentley, N. J., Holtzman, D. A., Flaggs, G., Keegan, K. S., DeMaggio, A., Ford, J. C., Hoekstra, M., & Carr, A. M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01054.x · Cited by 369 · cited 2×
“Although it is evident that Rad3p, and its Saccharomyces cerevisiae homologue Mec1p, are essential for cell cycle checkpoint arrest following DNA damage or replication block, the lack of mammalian cell lines containing null mutations in both ATR alleles has severely hampered e orts to de®ne the physiological functions…”
BackgroundCritical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2
Unger, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1805 · Cited by 367 · cited 3×
“More recently, it has been demonstrated that mutation of serine-20 renders p53 less stable and more prone to Mdm2 mediated degradation (Unger et al., 1999).”
BackgroundInfluentialNucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53
Tao, W., & Levine, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3077 · Cited by 355 · cited 1×
“More speci®cally, Mdm2 is believed to translocate p53 from the nucleus of the cell into the cytoplasm, where it then undergoes degradation (Dobbelstein et al., 1998; Freedman and Levine, 1998; Tao and Levine, 1999).”
BackgroundJayaraman, L., & Prives, C. (1995) · Cell · doi:10.1016/s0092-8674(05)80007-8 · Cited by 345 · cited 1×
“Furthermore, synthetic peptides derived from the p53 C-terminus can interact with the C-terminal regulatory domain and activate p53 sequence-speci®c DNA binding (Hupp et al., 1995; Jayaraman and Prives, 1995; Lee et al., 1995; Selivanova et al., 1997; Muller-Tiemman et al., 1998).”
BackgroundSelivanova, G., Iotsova, V., Okan, I., Fritsche, M., Ström, M., Groner, B., Grafström, R. C., & Wiman, K. G. (1997) · Nature Medicine · doi:10.1038/nm0697-632 · Cited by 343 · cited 1×
“Furthermore, synthetic peptides derived from the p53 C-terminus can interact with the C-terminal regulatory domain and activate p53 sequence-speci®c DNA binding (Hupp et al., 1995; Jayaraman and Prives, 1995; Lee et al., 1995; Selivanova et al., 1997; Muller-Tiemman et al., 1998).”
BackgroundHuman p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.
Bischoff, J. R., Friedman, P. N., Marshak, D. R., Prives, C., & Beach, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4766 · Cited by 342
Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases
Wang, Y., & Prives, C. (1995) · Nature · doi:10.1038/376088a0 · Cited by 336 · cited 2×
“…domains by a number of di erent kinases, including cyclin dependent kinases (Cdks) at serine-315 (Bischo et al., 1990; Price et al., 1995; Wang and Prives, 1995), casein kinase I (CKI) at serine-6 and serine-9 (Milne et al., 1992), casein kinase II (CKII) at serine-392 (Hall et al.,…”
BackgroundRotman, G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.10.1555 · Cited by 328 · cited 1×
“…approximately 100- fold increased incidence of cancer, in addition to A-T cells exhibiting chromosomal instability and radiosensitivity, has led to speculation that the A-T gene product may somehow be involved in the detection and signalling of DNA damage (for review see Rotman and Shiloh, 1998).”
BackgroundPositional cloning of the gene for Nijmegen breakage syndrome
Matsuura, S., Tauchi, H., Nakamura, A., Kondo, N., Sakamoto, S., Endo, S., Smeets, D., Solder, B., Belohradsky, B. H., Der Kaloustian, V. M., et al. (1998) · Nature Genetics · doi:10.1038/549 · Cited by 328 · cited 2×
“Indeed, similar to A-T cells, two independent studies have reported that induction of p53 in response to IR is defective in NBS cells, although defects in phosphorylation events in vivo were not assessed in these studies (Jongmans et al., 1997; Matsuura et al., 1998b).”
BackgroundMethodp53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding
Midgley, C. A., & Lane, D. P. (1997) · Oncogene · doi:10.1038/sj.onc.1201459 · Cited by 311 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
DNA-dependent protein kinase acts upstream of p53 in response to DNA damage
Woo, R. A., McLure, K. G., Lees-Miller, S. P., Rancourt, D. E., & Lee, P. W. K. (1998) · Nature · doi:10.1038/29343 · Cited by 309 · cited 1×
“Nevertheless, and somewhat contradictory with the above reports, Woo et al. (1998) have presented evidence that DNA-PK is crucial, although not su cient, for the upregulation of p53 DNA binding potential in response to DNA damage.”
ResultUbiquitination of p53 and p21 Is Differentially Affected by Ionizing and UV Radiation
Maki, C. G., & Howley, P. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.355 · Cited by 308 · cited 2×
“A variety of studies have revealed that p53 has an extremely short half-life in an unstressed cell, but becomes markedly more stable following DNA damage (Maltzman and Czyzyk, 1984; Price and Calderwood, 1993; Maki and Howley, 1997).”
BackgroundA human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase
Blasina, A., de Weyer, I. V., Laus, M. C., Luyten, W. H. M. L., Parker, A. E., & McGowan, C. H. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80041-4 · Cited by 303 · cited 1×
“In this regard, it will be of interest to establish whether kinases that act downstream of ATM in DNA damage signalling pathways such as Chk1 and Chk2 (Matsouka et al., 1998; Blasina et al., 1999; Brown et al., 1999; Chen et al., 1999), are also capable of targeting p53.”
BackgroundAllosteric activation of latent p53 tetramers
Hupp, T. R., & Lane, D. P. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00195-0 · Cited by 301 · cited 2×
“…phosphorylation events being involved in regulating p53 activity, phosphorylation of the p53 C-terminal regulatory domain by CKII, PKC or Cdks has been shown to activate p53 sequence-speci®c DNA binding in vitro (Hupp et al., 1992; Hupp and Lane, 1994; Takenaka et al., 1995; Wang and Prives, 1995).”
BackgroundShieh, S.-Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1815 · Cited by 300 · cited 1×
“Thus, Shieh et al. (1999) have shown that in addition to serine-15, serine-20 is also phosphorylated in response to DNA damage.”
BackgroundNegative feedback regulation of wild-type p53 biosynthesis.
Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F., & Deppert, W. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00123.x · Cited by 286 · cited 1×
“In this regard, both the 5' and 3' untranslated regions of p53 mRNA have been implicated in regulating p53 mRNA translation (Mosner et al., 1995; Fu and Benchimol, 1997).”
BackgroundBaudier, J., Delphin, C., Grunwald, D., Khochbin, S., & Lawrence, J. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11627 · Cited by 285 · cited 1×
“…at serine-6 and serine-9 (Milne et al., 1992), casein kinase II (CKII) at serine-392 (Hall et al., 1996), protein kinase C (PKC) at serine-378 (Baudier et al., 1992), mitogen-activated protein kinase (MAPK) at threonine-73 and threonine-83 of mouse p53 (Milne et al., 1994), Jun amino-terminal…”
BackgroundKeegan, K. S., Holtzman, D. A., Plug, A. W., Christenson, E. R., Brainerd, E. E., Flaggs, G., Bentley, N. J., Taylor, E. M., Meyn, M. S., Moss, S. B., et al. (1996) · Genes & Development · doi:10.1101/gad.10.19.2423 · Cited by 282 · cited 1×
“Signi®cantly, ATR immunoprecipitates have been shown to contain an associated kinase activity (Keegan et al., 1996) and, similar to ATM, ATR catalytic activity has been found to mediate phosphorylation of p53 at serine-15 in vitro (Canman et al., 1998; Tibbetts et al., 1999).”
BackgroundV(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors.
Guidos, C. J., Williams, C. J., Grandal, I., Knowles, G., Huang, M. T., & Danska, J. S. (1996) · Genes & Development · doi:10.1101/gad.10.16.2038 · Cited by 275 · cited 1×
“…carrying mutations in DNA-PKcs, or in mice containing a targeted disruption in the genes for Ku80 or Ku70 (Bogue et al., 1996; Fried et al., 1996; Guidos et al., 1996; Huang et al., 1996b; Jongmans et al., 1996; Nacht et al., 1996; Candeias et al., 1997; Gu et al., 1997b; Nussenzweig et al.,…”
BackgroundcDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein.
Cimprich, K. A., Shin, T. B., Keith, C. T., & Schreiber, S. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2850 · Cited by 273 · cited 1×
“One candidate for another kinase that could signal to p53 in response to DNA damage is the ATM-related polypeptide ATR, which is the mammalian homologue of the Schizosaccharomyces pombe cell cycle checkpoint protein Rad3p (Bentley et al., 1996; Cimprich et al., 1996).”
BackgroundThe p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.
Canman, C. E., Wolff, A. C., Chen, C.-Y., Fornace, A. J., & Kastan, M. B. (1994) · PubMed · Cited by 272
Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.
Chen, C. Y., Oliner, J. D., Zhan, Q., Fornace, A. J., Vogelstein, B., & Kastan, M. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2684 · Cited by 271 · cited 1×
“Taken together with the fact that over-expression of Mdm2 was shown to be capable of inhibiting IR-induced p53-dependent G1 arrest (Chen et al., 1994), these ®ndings strongly suggest that Mdm2 is a physiological negative modulator of p53 activity.”
BackgroundUnger, T., Nau, M. M., Segal, S., & Minna, J. D. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05183.x · Cited by 261 · cited 1×
“This region, which encompasses amino acid residues 1 ± 43 of the p53 polypeptide (Unger et al., 1992), has been shown to interact in vitro with protein components of the basal transcriptional machinery, such as the TATA boxbinding protein (TBP), a number of TBP-associated factors (TAFs; for reviews…”
MethodBrown, A. L., Lee, C.-H., Schwarz, J. K., Mitiku, N., Piwnica-Worms, H., & Chung, J. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3745 · Cited by 261 · cited 1×
“In this regard, it will be of interest to establish whether kinases that act downstream of ATM in DNA damage signalling pathways such as Chk1 and Chk2 (Matsouka et al., 1998; Blasina et al., 1999; Brown et al., 1999; Chen et al., 1999), are also capable of targeting p53.”
BackgroundMilne, D. M., Campbell, L. E., Campbell, D. G., & Meek, D. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5511 · Cited by 257 · cited 2×
“…protein kinase (MAPK) at threonine-73 and threonine-83 of mouse p53 (Milne et al., 1994), Jun amino-terminal kinase (JNK) at serine-34 of mouse p53 (Milne et al., 1995), Raf kinase within the N-terminal 27 amino acid residues of p53 (Jamal and Zi , 1995), the DNAdependent protein kinase (DNA-PK)…”
BackgroundMethodThe mdm-2 gene is induced in response to UV light in a p53-dependent manner.
Perry, M. E., Piette, J., Zawadzki, J. A., Harvey, D., & Levine, A. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11623 · Cited by 247 · cited 1×
“Interestingly, the promoter of the Mdm2 gene contains a p53 binding site and is transcribed in a p53dependent manner (Barak et al., 1993; Perry et al., 1993; Wu et al., 1993).”
BackgroundAssociation of p300 and CBP with Simian Virus 40 Large T Antigen
Eckner, R., Ludlow, J. W., Lill, N. L., Oldread, E., Arany, Z., Modjtahedi, N., DeCaprio, J. A., Livingston, D. M., & Morgan, J. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3454 · Cited by 243 · cited 5×
“Thus, in addition to potentially playing a role in acetylating histones at p53-dependent promoters, CBP/p300 has been shown to be able to acetylate p53 at lysine-373 and lysine-382, whilst PCAF can acetylate p53 at lysine-320 (Gu and Roeder, 1997; Sakaguchi, 1998; Liu et al., 1999).”
BackgroundInfluentialMdm2 association with p53 targets its ubiquitination
Fuchs, S. Y., Adler, V., Buschmann, T., Wu, X., & Ronai, Z. (1998) · Oncogene · doi:10.1038/sj.onc.1202200 · Cited by 236 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
DNA damage and the DNA-activated protein kinase
Anderson, C. W. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90144-c · Cited by 235 · cited 1×
“Binding of DNA-PK to DNA ends in vitro is required for it to phosphorylate a number of di erent substrates, including p53 (for review see Anderson, 1993; Smith and Jackson, 1999).”
BackgroundTranscriptional activation by p53 correlates with suppression of growth but not transformation
CROOK, T. (1994) · Cell · doi:10.1016/0092-8674(94)90071-x · Cited by 233 · cited 1×
“…have illustrated that mutation of speci®c phosphorylation sites in p53 results in no abrogation of either p53 functional activity or up-regulation of p53 levels in response to DNA damage (for example Slingerland et al., 1993; Crook et al., 1994; Fiscella et al., 1994; Blattner et al., 1999).”
BackgroundWright, J. A., Keegan, K. S., Herendeen, D. R., Bentley, N. J., Carr, A. M., Hoekstra, M. F., & Concannon, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7445 · Cited by 226 · cited 1×
“…that overexpression of a kinase-inactive (kinase-dead) dominant negative form of ATR renders cells hypersensitive to a variety of DNA damaging agents, illustrating that ATR is indeed involved in the detection and signalling of DNA damage in mammalian cells (Cliby et al., 1998; Wright et al., 1998).”
BackgroundIdentification of new genes required for meiotic recombination in Saccharomyces cerevisiae.
Ajimura, M., Leem, S. H., & Ogawa, H. (1993) · Genetics · doi:10.1093/genetics/133.1.51 · Cited by 218
Functional activation of p53 via phosphorylation following DNA damage by UV but not γ radiation
Kapoor, M., & Lozano, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2834 · Cited by 211 · cited 2×
“Thus, although p53 is phosphorylated on serine-15 in response to IR or UV, the CKII site situated at serine-392 in human p53 has been shown to be phosphorylated in response to UV but not IR (Kapoor and Lozano, 1998; Lu et al., 1998; Blaydes and Hupp, 1998).”
BackgroundThe ATM-Related Cofactor Tra1 Is a Component of the Purified SAGA Complex
Grant, P. A., Schieltz, D., Pray-Grant, M. G., Yates, J. R., & Workman, J. L. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80300-7 · Cited by 198 · cited 1×
“However, unlike DNA-PK, ATM and ATR, TRRAP appears to contain no intrinsic kinase activity, but instead copuri®es both in yeast and mammals with protein complexes that contain HAT activity (Grant et al., 1998; McMahon et al., 1998; Saleh et al., 1998; Vassilev et al., 1998).”
BackgroundTakenaka, I., Morin, F., Seizinger, B. R., & Kley, N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5405 · Cited by 197 · cited 1×
“…phosphorylation events being involved in regulating p53 activity, phosphorylation of the p53 C-terminal regulatory domain by CKII, PKC or Cdks has been shown to activate p53 sequence-speci®c DNA binding in vitro (Hupp et al., 1992; Hupp and Lane, 1994; Takenaka et al., 1995; Wang and Prives, 1995).”
BackgroundWild-type p53 adopts a ‘mutant’-like conformation when bound to DNA.
Halazonetis, T. D., Davis, L. J., & Kandil, A. N. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05743.x · Cited by 193 · cited 1×
“Interestingly, deletion of the C-terminal 30 amino acid residues of p53 results in activation of sequence-speci®c DNA binding (Hupp et al., 1992; Halazonetis et al., 1993), illustrating that p53 contains a negative regulatory domain in its C-terminus, and suggesting that this domain might be…”
BackgroundDvir, A., Stein, L. Y., Calore, B. L., & Dynan, W. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82219-0 · Cited by 183
p53 Is Phosphorylated by CDK7-Cyclin H in a p36MAT1-Dependent Manner
Ko, L. J., Shieh, S.-Y., Chen, X., Jayaraman, L., Tamai, K., Taya, Y., Prives, C., & Pan, Z.-Q. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7220 · Cited by 173 · cited 1×
“Serine-33 is the major phosphorylation site in vitro for the Cdk-activated kinase (CAK; Ko et al., 1997).”
BackgroundMutations in the p53 and SCID genes cooperate in tumorigenesis.
Nacht, M., Strasser, A., Chan, Y. R., Harris, A. W., Schlissel, M., Bronson, R. T., & Jacks, T. (1996) · Genes & Development · doi:10.1101/gad.10.16.2055 · Cited by 172 · cited 1×
“…a targeted disruption in the genes for Ku80 or Ku70 (Bogue et al., 1996; Fried et al., 1996; Guidos et al., 1996; Huang et al., 1996b; Jongmans et al., 1996; Nacht et al., 1996; Candeias et al., 1997; Gu et al., 1997b; Nussenzweig et al., 1996; Rathmell et al., 1997; Abraham et al., 1999).”
BackgroundThe 400 kDa Subunit of the PCAF Histone Acetylase Complex Belongs to the ATM Superfamily
Vassilev, A., Yamauchi, J., Kotani, T., Prives, C., Avantaggiati, M. L., Qin, J., & Nakatani, Y. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80301-9 · Cited by 162 · cited 1×
“However, unlike DNA-PK, ATM and ATR, TRRAP appears to contain no intrinsic kinase activity, but instead copuri®es both in yeast and mammals with protein complexes that contain HAT activity (Grant et al., 1998; McMahon et al., 1998; Saleh et al., 1998; Vassilev et al., 1998).”
BackgroundLu, H., Taya, Y., Ikeda, M., & Levine, A. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6399 · Cited by 162 · cited 1×
“Thus, although p53 is phosphorylated on serine-15 in response to IR or UV, the CKII site situated at serine-392 in human p53 has been shown to be phosphorylated in response to UV but not IR (Kapoor and Lozano, 1998; Lu et al., 1998; Blaydes and Hupp, 1998).”
BackgroundResponses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family
Hoekstra, M. F. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80125-6 · Cited by 161 · cited 1×
“However, this family of proteins has recently been expanded by the identi®cation of a subset of these proteins that appear to function primarily, if not exclusively, as protein kinases (for reviews see Jackson, 1996; Hoekstra, 1997).”
BackgroundPhosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases.
Milne, D. M., Campbell, D. G., Caudwell, F. B., & Meek, D. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37101-6 · Cited by 156
DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
Blattner, C., Tobiasch, E., Litfen, M., Rahmsdorf, H. J., & Herrlich, P. (1999) · Oncogene · doi:10.1038/sj.onc.1202480 · Cited by 151 · cited 1×
“…have illustrated that mutation of speci®c phosphorylation sites in p53 results in no abrogation of either p53 functional activity or up-regulation of p53 levels in response to DNA damage (for example Slingerland et al., 1993; Crook et al., 1994; Fiscella et al., 1994; Blattner et al., 1999).”
BackgroundTra1p Is a Component of the Yeast Ada·Spt Transcriptional Regulatory Complexes
Saleh, A., Schieltz, D., Ting, N., McMahon, S. B., Litchfield, D. W., Yates, J. R., Lees-Miller, S. P., Cole, M. D., & Brandl, C. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26559 · Cited by 133 · cited 1×
“However, unlike DNA-PK, ATM and ATR, TRRAP appears to contain no intrinsic kinase activity, but instead copuri®es both in yeast and mammals with protein complexes that contain HAT activity (Grant et al., 1998; McMahon et al., 1998; Saleh et al., 1998; Vassilev et al., 1998).”
BackgroundJongmans, W., Vuillaume, M., Chrzanowska, K., Smeets, D., Sperling, K., & Hall, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5016 · Cited by 117 · cited 1×
“Indeed, similar to A-T cells, two independent studies have reported that induction of p53 in response to IR is defective in NBS cells, although defects in phosphorylation events in vivo were not assessed in these studies (Jongmans et al., 1997; Matsuura et al., 1998b).”
BackgroundFu, L., & Benchimol, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.4117 · Cited by 116 · cited 1×
“In this regard, both the 5' and 3' untranslated regions of p53 mRNA have been implicated in regulating p53 mRNA translation (Mosner et al., 1995; Fu and Benchimol, 1997).”
BackgroundDNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site
Blaydes, J. P., & Hupp, T. R. (1998) · Oncogene · doi:10.1038/sj.onc.1202014 · Cited by 109 · cited 1×
“Thus, although p53 is phosphorylated on serine-15 in response to IR or UV, the CKII site situated at serine-392 in human p53 has been shown to be phosphorylated in response to UV but not IR (Kapoor and Lozano, 1998; Lu et al., 1998; Blaydes and Hupp, 1998).”
BackgroundSlingerland, J., Jenkins, J. R., & Benchimol, S. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05744.x · Cited by 104 · cited 1×
“…have illustrated that mutation of speci®c phosphorylation sites in p53 results in no abrogation of either p53 functional activity or up-regulation of p53 levels in response to DNA damage (for example Slingerland et al., 1993; Crook et al., 1994; Fiscella et al., 1994; Blattner et al., 1999).”
BackgroundBogue, M. A., Zhu, C., Aguilar-Cordova, E., Donehower, L. A., & Roth, D. B. (1996) · Genes & Development · doi:10.1101/gad.10.5.553 · Cited by 102 · cited 3×
“Puri®cation and subsequent analysis of DNA-PK by a number of laboratories revealed that DNA-PK consists of a large catalytic subunit (DNAPKcs) that is targeted to DNA ends by the Ku heterodimer, which consists of the polypeptides Ku70 and Ku80 (Dvir et al., 1993; Gottlieb and Jackson, 1993).”
BackgroundGoldman, S. C., CHEN, C.-Y., Lansing, T. J., Gilmer, T. M., & Kastan, M. (1996) · Europe PMC (PubMed Central) · Cited by 97
Fried, L. M., Koumenis, C., Peterson, S. R., Green, S. L., van Zijl, P., Allalunis-Turner, J., Chen, D. J., Fishel, R., Giaccia, A. J., Brown, J. M., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13825 · Cited by 93 · cited 1×
“…normal in cell lines carrying mutations in DNA-PKcs, or in mice containing a targeted disruption in the genes for Ku80 or Ku70 (Bogue et al., 1996; Fried et al., 1996; Guidos et al., 1996; Huang et al., 1996b; Jongmans et al., 1996; Nacht et al., 1996; Candeias et al., 1997; Gu et al., 1997b;…”
BackgroundIdentification of an additional negative regulatory region for p53 sequence-specific DNA binding
Müller-Tiemann, B. F., Halazonetis, T. D., & Elting, J. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6079 · Cited by 89
Rathmell, W. K., Kaufmann, W. K., Hurt, J. C., Byrd, L. L., & Chu, G. (1997) · PubMed · Cited by 82
Hall, S. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.6.1119 · Cited by 74 · cited 1×
“…et al., 1995; Wang and Prives, 1995), casein kinase I (CKI) at serine-6 and serine-9 (Milne et al., 1992), casein kinase II (CKII) at serine-392 (Hall et al., 1996), protein kinase C (PKC) at serine-378 (Baudier et al., 1992), mitogen-activated protein kinase (MAPK) at threonine-73 and…”
BackgroundAdenovirus E1A Proteins Inhibit Activation of Transcription by p53
Steegenga, W. T., Laar, T. V., Riteco, N., Mandarino, A., Shvarts, A., Van Der Eb, A. J., & Jochemsen, A. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2101 · Cited by 73 · cited 1×
“Furthermore, reports that E1A can bind to either p300/CBP or p53, interfering with the transcriptional activity of p53, has lent support to this idea (Steegenga et al., 1996; Lill et al., 1997).”
Phosphorylation sites in the amino-terminal region of mouse p53.
Wang, Y., & Eckhart, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4231 · Cited by 72 · cited 1×
“One of the ®rst demonstrations that p53 is phosphorylated in vivo was provided by Wang and Eckhart (1992) who, by a phospho-peptide mapping approach, demonstrated that cellular mouse p53 is phosphorylated at serine residues 7, 9, 18 and 37.”
BackgroundYamazaki, V., Wegner, R. ‐., & Kirchgessner, C. U. (1998) · PubMed · Cited by 69
DNA repair: The Nijmegen breakage syndrome protein
Featherstone, C., & Jackson, S. P. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70392-6 · Cited by 67 · cited 2×
“However, it does contain two domains that have been identi®ed in proteins involved in the detection and signalling of DNA damage, namely a forkhead-associated (FHA) domain, and a breast cancer carboxy-terminal (BRCT) domain (for review see Featherstone and Jackson, 1998).”
BackgroundSelf-citationMatsuura, K., Balmukhanov, T. S., Tauchi, H., Weemaes, C. M. R., Smeets, D. F. C. M., Chrzańowska, K., Endou, S., Matsuura, S., & Komatsu, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7924 · Cited by 51 · cited 2×
“Indeed, similar to A-T cells, two independent studies have reported that induction of p53 in response to IR is defective in NBS cells, although defects in phosphorylation events in vivo were not assessed in these studies (Jongmans et al., 1997; Matsuura et al., 1998b).”
BackgroundMethodZhang, W., McClain, C., Gau, J., Guo, X., & Deisseroth, A. B. (1994) · PubMed · Cited by 48
Chk1 complements the G2/M checkpoint defect and radiosensitivity of ataxia-telangiectasia cells
Chen, P., Gatei, M. H., O’Connell, M. J., Khanna, K. K., Bugg, S. J., Hogg, A., Scott, S. P., Hobson, K., & Lavin, M. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202257 · Cited by 45 · cited 1×
“In this regard, it will be of interest to establish whether kinases that act downstream of ATM in DNA damage signalling pathways such as Chk1 and Chk2 (Matsouka et al., 1998; Blasina et al., 1999; Brown et al., 1999; Chen et al., 1999), are also capable of targeting p53.”
BackgroundWolfe, M. (1996) · ACM Computing Surveys · doi:10.1145/234313.234417 · Cited by 32
Abraham, J., Spaner, D., & Benchimol, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202454 · Cited by 23 · cited 1×
“…a targeted disruption in the genes for Ku80 or Ku70 (Bogue et al., 1996; Fried et al., 1996; Guidos et al., 1996; Huang et al., 1996b; Jongmans et al., 1996; Nacht et al., 1996; Candeias et al., 1997; Gu et al., 1997b; Nussenzweig et al., 1996; Rathmell et al., 1997; Abraham et al., 1999).”
Backgroundp53-dependent apoptosis and transcription of p21waf/cip1/sdi1 in SCID mice following γ-irradiation
Candéias, S. M., Durum, S. K., & Muegge, K. (1997) · Biochimie · doi:10.1016/s0300-9084(97)82010-x · Cited by 15 · cited 1×
“…a targeted disruption in the genes for Ku80 or Ku70 (Bogue et al., 1996; Fried et al., 1996; Guidos et al., 1996; Huang et al., 1996b; Jongmans et al., 1996; Nacht et al., 1996; Candeias et al., 1997; Gu et al., 1997b; Nussenzweig et al., 1996; Rathmell et al., 1997; Abraham et al., 1999).”
BackgroundThe vagaries of paraphrase: a reply to Holton on the counting problem
Rumfitt, I. (1996) · Analysis · doi:10.1093/analys/56.4.246 · Cited by 7
ELECTROMAGNETIC FIELD IN SOME ANISOTROPIC STIFF FLUID UNIVERSES
Pimentel, L. O. (1995) · Modern Physics Letters A · doi:10.1142/s0217732395002246 · Cited by 2
Research works printed but not linked: 3
- Lakin ND, Hann BC and Jackson SP. . 1999 Oncogene in press.
- Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. . 1992 Mol. Cell. Biol. 12: 5041–5049. · doi:10.1128/mcb.12.11.5041-5049.1992 · Paper page
- Maltzman W and Czyzyk L. . 1984 Mol. Cell. Biol. 4: 1689–1694. · DOI · Paper page
Cited by
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
“Intracellular factors that may inhibit such an activation of p53 include overexpression of the negative feedback regulator Mdm2 and downregulation of the moderator of Mdm2, p14ARF (Fritsche et al., 1993; Shieh et al., 1997; Lakin and Jackson, 1999; Meek, 1999; Deng et al., 2002).”
BackgroundRegulation of the G2/M transition by p53
Taylor, W. R., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204252 · Cited by 1,559
“Phosphorylation of the amino-terminal region of p53 causes it to accumulate and stimulates its ability to bind to speci®c DNA sequences, essential steps in activating p53 in response to stress (Lakin and Jackson, 1999).”
BackgroundA large-scale RNAi screen in human cells identifies new components of the p53 pathway
Berns, K., Hijmans, E. M., Mullenders, J., Brummelkamp, T. R., Velds, A., Heimerikx, M., Kerkhoven, R. M., Madiredjo, M., Nijkamp, W., Weigelt, B., et al. (2004) · Nature · doi:10.1038/nature02371 · Cited by 1,065
“Figure 2d shows that exposure of U2-OS cells to ionizing radiation (IR) causes these cells to withdraw from S phase and arrest both in the G1 phase of the cell cycle (a p53-dependent proces”
Dynamics of the p53-Mdm2 feedback loop in individual cells
Lahav, G., Rosenfeld, N., Sigal, A., Geva-Zatorsky, N., Levine, A. J., Elowitz, M. B., & Alon, U. (2004) · Nature Genetics · doi:10.1038/ng1293 · Cited by 1,013
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
“and MDMX, which promote p53 degradation through ubiquitination.(27,28) When cells are exposed to internal and external stresses, including DNA damage, hypoxia, nutrient deprivation, and cancer cell risk, p53 ubiquitination is inhibited, triggering a rapid increase in intracellular p53 protein levels.”
Background
Metadata
- Authors
- Lakin, N. D., & Jackson, S. P.
- Affiliations
- University of Cambridge (GB)
- ORCID
- Jackson, Stephen P
- Venue
- Oncogene
- Published
- 1999-12-13
- Volume
- 18
- Issue
- 53
- Pages
- 7644-7655
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2007935491
- Cited by
- 987
- References
- 128
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 30 · 2023: 54 · 2022: 57 · 2021: 46 · 2020: 46 · 2019: 33 · 2018: 40 · 2017: 43 · 2016: 34 · 2015: 33 · 2014: 28 · 2013: 23 · 2012: 28
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, DNA damage response, p53 activation, post-translational modification, phosphorylation, dephosphorylation, acetylation, ionizing radiation, ultraviolet radiation, methyl methanesulfonate, cell cycle arrest, apoptosis, DNA repair, transcriptional activation, hypoxia
- MeSH terms
- Adenosine Triphosphatases, Animals, DNA Damage, DNA Helicases, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Signal Transduction, Trans-Activators, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Saccharomyces cerevisiae Proteins, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.